Prevalence and Impact of Inflammatory Bowel Disease–Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners
In this study, we aimed to evaluate the prevalence of IBD–IBS and investigate its impact on patient-reported outcomes.
Method: We performed a cross-sectional analysis within the CCFA Partners Study. Bivariate analyses and logistic regression models were used to investigate associations between IBD–IBS and various demographic, disease factors, and patient-reported outcomes including anxiety, depression, sleep disturbances, pain interference, and social satisfaction.
Results: Of the 6309 participants included, a total of 1279 (20%) reported a coexisting IBS diagnosis. The prevalence of IBD–IBS in this cohort was similar within disease subtypes. A diagnosis of IBD–IBS was associated with higher narcotic use compared with those with no IBS diagnosis for both Crohn's disease, 17% versus 11% (P
Source: Inflammatory Bowel Diseases - Category: Gastroenterology Tags: Original Clinical Article Source Type: research
More News: Anxiety | Crohn's Disease | Depression | Inflammatory Bowel Disease | Irritable Bowel Syndrome | Pain | Sleep Disorders | Sleep Medicine | Study